Capricor Therapeutics (NasdaqCM:CAPR) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsAJ Bergmann - CFOLinda Marbán - CEOConference Call ParticipantsBoobalan Pachaiyappan - Managing Director and Senior Biotech AnalystCatherine Novack - Healthcare AnalystEdward Tenthoff - Managing Director and Senior Research AnalystJoe Pantginis - Managing Director and Senior Healthcare AnalystKristen Kluska - Managing Director and Biotechnology Equity Research AnalystLeland Gershell - Managing Director ...

Capricor Therapeutics (NasdaqCM:CAPR) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Company ParticipantsAJ Bergmann - CFOLinda Marbán - CEOConference Call ParticipantsBoobalan Pachaiyappan - Managing Director and Senior Biotech AnalystCatherine Novack - Healthcare AnalystEdward Tenthoff - Managing Director and Senior Research AnalystJoe Pantginis - Managing Director and Senior Healthcare AnalystKristen Kluska - Managing Director and Biotechnology Equity Research AnalystLeland Gershell - Managing Director ...

Capricor Therapeutics (NasdaqCM:CAPR) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker10Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics fourth quarter and full year 2025 conference call. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call may be recorded today, Thursday, Mar ...